# ERTAPENEM SODIUM
> **ANDA209145** · Abbreviated New Drug Application (Generic) · Sponsor: SUN PHARM · Approved 2023-05-02
## Drug
- **FDA Application Number:** ANDA209145
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ERTAPENEM SODIUM
- **Generic name:** Ertapenem Sodium
- **Active ingredients:** ERTAPENEM SODIUM
- **Dosage form:** INJECTABLE
- **Route:** INTRAMUSCULAR, INTRAVENOUS
- **Marketing status:** Discontinued
- **Sponsor:** SUN PHARM
- **First approval:** 2023-05-02
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209145)
---
*MORVS · CC0 1.0*